Life Science Investing Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference 02 September
Life Science Investing Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update 14 August
